| Botanical name | Common name | Bioactive compound | Indication | Target | Probe drug | Effect | Study | References |
| Acacia nilotica | Gum Arabic | Acanilol A, acanilol B, kaempferol | Diabetes | P-gp | Cyclosporin A | Synergism | In vitro | [57–59] |
| Aframomum melegueta (Roscoe) K. Schum | Alligator pepper | Humulene, saryophyllene | Diabetes | CYP3A4, CYP3A5, CYP3A7 | Ketoconazole | Synergism | In vitro | [60, 61] |
| Bixa orellana | Lipstick tree | Bixin | Diabetes | CYP1A1/2, CYP2B1/2, CYP3A | Pentoxyresorufin, Benzyloxyresorufin | Antagonism | In vitro | [62, 63] |
| Capsicum annuum | Red chilli pepper | Capsaicin | Hypertension | P-gp | Daunorubicin, Rhodamine-123 | Synergism | In vitro | [64] |
| Carica papaya | Pawpaw | Carpain, alkaloids, terpenes, flavanols | Diabetes | P-gp, | Digoxin, amiodarone | Synergism | In vivo, in vitro | [65–67] |
| Catha edulis | Khat | Cathinones | Diabetes | CYP2D6 | Dextromethorphan | Synergism | In vitro/in vivo (human) | [68, 69] |
| Centella asiatica | Centella | Triterpenes, asiatic acid | Hypertension | CYP2C9, CYP3A4 | Tolbutamide | Synergism | In vitro | [70, 71] |
| Citrus aurantifolia (Christm.) Swingle | Lime | Imperatorin, kaempferol, myricetin, β- sitosterol | Diabetes | CYP 2B6 | Bupropion | Synergism | In vitro | [72, 73] |
| Citrus aurantium L. | Sour orange | Methoxyflavones | Diabetes | Intestinal CYP3A4, P-gp | Felodipine Vinblastine | Synergism | In vivo (human) | [74, 75] | Auraptene, nobiletin | Cancer | P-gp | Daunorubicin | Synergism | In vitro | [76] |
| Corchorus olitorius | Long fruited jute | 3,5-Dicaffeoylquinic acid | Diabetes | CYP3A4 | Ketoconazole | Synergism | In vitro | [60, 77] |
| Curcuma longa | Turmeric | Curcumin | Diabetes | CYP3A4, CYP2C8, CYP2C9, CYP1A2, CYP2A6, CYP2D6, CYP2B6 | Pioglitazone, caffeine, daunorubicin | Synergism/antagonism on CYP2A6 | In vitro, in vivo (human) | [78–81] |
| Ipomea batatas | Sweet potato | 6-O-caffeoylsophorose, 4-ipomeanol acylated cyanidin, peonidin | Diabetes | P-gp | Rhodamine-123 | Synergism | In vitro | [82] |
| Jatropha curcas L. | Purging nut | Coumarins, Jatrophalactam, Jatrogrossidione derivatives | Diabetes | CYP3A4, CYP3A7 | Ketoconazole | Synergism | In vitro | [60, 83] |
| Morinda lucida Benth. | Brimstone tree | Anthraquinones | Diabetes | P-gp | Digoxin | Synergism | In vitro | [65, 84] |
| Murraya koenigii (L.)Spreng. | Sweet neem | Girinimbine, mahanimbilol, koenimbine, Xanthotoxin | Diabetes | CYP1A2, CYP2C9, CYP2D6, CYP3A4 | Ketoconazole, quinidine, sulfaphenazole, α-naphthoflavone | Synergism | In vitro | [85–87] |
| Persea americana Mill. | Avocado pear | Caryophyllene oxide, α- and β-pinene, caryophyllene | Diabetes | CYP 3A4, CYP3A5, CYP3A7 | Ketoconazole | Synergism | In vitro | [60, 88] |
| Sesamum indicum | Sesame | Sesamin | Dietary nutrient | P-gp (MDR1) | Daunorubicin | Synergism | In vitro | [89] |
| Vernonia amygdalina | Bitter leaf | Sesquiterpene lactones, steroidal glycosides | Diabetes | P-gp | Digoxin | Synergism | In vitro | [65, 90] |
|
|